UK Markets closed

SPDR Gold Shares (GLD)

NYSEArca - Nasdaq Real-time price. Currency in USD
Add to watchlist
171.09-0.56 (-0.33%)
At close: 04:00PM EST
171.47 +0.38 (+0.22%)
After hours: 07:59PM EST
Sign in to post a message.
  • T
    Tom
    Why is there a clause in the GLD prospectus that states GLD has no right to audit subcustodial gold holdings? Why would the organizations behind GLD forfeit this right and create this massive audit loophole? I haven't heard of a single good reason for the existence of this loophole so far. In addition to the audit loophole, GLD claims to be fully backed by physical gold bullion but yet it refuses to give retail investors the right to redeem for any of these ‘claimed’ gold bullion. There are other issues as well that I welcome everyone to verify for themselves:

    "CNBC's Bob Pisani also made a highly publicized visit to GLD's gold vault in a segment called Gold Rush: The Mother Lode. GLD's administration organized this visit to show that GLD's gold actually exists. However, the gold bar held up by Mr. Pisani showed a serial number of ZJ6752 which did not show up on the latest bar list during that time. It was later found that this "GLD" bar actually belonged to ETF Securities..."

    "Did anyone try calling the GLD hotline at 866 320 4053 in search of numerical details on GLD's insurance? The prospectus vaguely states "The Custodian maintains insurance with regard to its business on such terms and conditions as it considers appropriate which does not cover the full amount of gold held in custody." When I asked about how much of the gold was insured, the representative proceeded to act as if he didn't know and said they were just the "marketing agent" for GLD. What kind of marketing agent would not know such basic information about a product they are marketing? It seems like they are deliberately hiding information from investors. The people behind GLD do not seem like the most honest types."
  • W
    Warren
    I have been in trading since 2012 and I have made so many wrong investment. Following wrong predictions and analysis and making lot of losses. Ever since I started trading with Bernard Mikhail signals in August, I have have made over 820k profits with his accurate signals and guide. I urge everyone and newbies to take advantage of his strategy. Reach out to him on 🆃🅴🅻🅴🅶🆁🅼 : Mikhailsignals <<<<
  • T
    Tammy
    Our favorite DVAX biotech will explode with excellent quarter results!!

    Also as I have predicted SNPX Alzheimer's drug Company will be LAUNCHING much sooner than I had expected.

    It's definitely next SAVA 100x stock next 12 months. It's pretty speculative and not as easy money as DVAX biotech.

    But if NIH clinical trials currently underway come out positive, it will 50x easy by next spring just like SAVA or BIOGEN Alzheimer's treatment drug companies.

    SNPX Alzheimer's drug Company is lottery stock and not safe easy money making machine like DVAX biotech.
  • M
    Matthew
    Guess who’s back? Me. I just happened to run across an article showing the best performing assets of 2021. Guess what was at the top? Nope you’re wrong, it wasn’t gold. It was bitcoin with a staggering 59.8% return for the year. You may be wondering what the return was for gold but don’t worry I got you. It was a whopping NEGATIVE 3.6%. So here I am almost a year later trying to figure out why you guys aren’t expanding your portfolios and are still denying bitcoin yet choose to make investments that track gold. Right now at this point in time you are getting a chance to start a position on bitcoin at prices that will likely never be seen again in the next 3-5 years. Maybe even sooner. This is your chance to add an asset to you long term portfolio that I will almost guarantee it will be the best investment of your life. I know it will outperform any traditional assets you invest in like gold,silver,S&P etc. There’s a reason Bitcoin has been the best performing asset the last decade and it’s not because it’s a “scam” or only for “illicit activities”. It’s because it’s here to stay and provides value. Bitcoin is not going away and neither is crypto in general. So why not get out of your old fashioned ways and enter the realm of now. What’s currently happening and what’s currently providing genuine value to not only the everyday people but to economies all over the WORLD. All financial markets are shaky right now and I suspect we continue to see volatility for possibly many more months due to the feds tightening their monetary policies,interest rates raising, inflation on the rise, political tensions across the globe. The question from an investment stand point is what will rebound the quickest and provide the best returns? There’s only one right answer and that is bitcoin/crypto in general. Good luck my friends and remember these are the times when the real money is made. Buying when others are panicking and selling or sitting on the sidelines because they are scared. I ll be back in 6 months to check in on how gold is performing and hopefully a few of you will have taken the time by then to really research crypto and all it has to offer. If you want 2022 to be better than 2021 then don’t do what you did in 2021. Try something new like I don’t know investing into a market that is still tremendously undervalued as whole and growing exponentially year after year.
  • C
    Carmen
    RDUS phase 3 topline makes it a buyout candidate. Heavily undervalued!
  • G
    Grace
    Just SENS it before their FDA approval!!
  • J
    June
    My faith in this company has been validated. When the Board deposed the CEO, I knew that VYGR was focused on commercializing AAV.
    More good news upcoming!
  • M
    Melissa
    BIVI --Phase 3 (Alzheimer Disease) data next year -Phase 2 (Parkinson disease) and many more in pipeline / Under radar stock =1000%+
  • S
    Steven
    From the report:

    - #1 Canadian LP in Global Medical Cannabis; Total Medical Cannabis Net Revenue Rose 9% Compared to Prior Year; Strong Adjusted Gross Margin before FVA of 68%
    - Business Transformation Plan on Track; Reiterates Annual Cost Savings of $60 Million to $80 Million, Providing Clear Pathway to Adjusted EBITDA Profitability
    - Balance Sheet Remains Strong with $440.9 Million of Cash at June 30, 2021; Working Capital Improves by $404.3 Million Compared to Prior Year
    - Adjusted EBITDA Loss, Excluding Restructuring Costs, Narrows to $13.9 Million, a $17.6 Million Improvement Compared to Prior Year
    - Total Cannabis Net Revenue, Net of Provisions, of $54.8 Million Compared to $55.2 Million in the Prior Quarter, and $67.5 Million in the Year-Ago Period.
  • L
    Lena
    CMI
    Maintains Morgan Stanley Equal-Weight USD 252 » USD 262
    Target Raised by Credit Suisse Outperform USD 295 » USD 304
  • C
    Charles
    Everything is going right with MGTX. Market cap = Hard manufacturing assets and cash. Pipeline is promising with J&J underwriting half of the pipeline along with milestone payments under a development agreement worth $440M---plus MGTX gets 20% of the backend profits of the J&J underwritten and marketed drugs.
  • A
    Amy
    Great Results! ASTR delivered on promise to customers and shareholders! Astra is a solid business to invest into with it's current mission and future endeavours.
  • J
    Jackie
    ESYJY
    Reiterated by Deutsche Bank » Buy » GBX 750
    Target Raised by Barclays Equal Weight GBX 685 » GBX 705
  • D
    Diane
    HUBS
    Maintains Wells Fargo Overweight » USD 750 » USD 835
    Maintains Canaccord Genuity Buy » USD 685 » USD 830
  • L
    Liza
    NET reminds me of Tesla a few years ago, keeps going up and so many naysayers around focusing on price instead of the value. NET brings huge value!
  • T
    Tiffany
    Semiconductor sector is hot! Don't let the intermittent pullbacks sway your positions. Global semiconductor sales are up big. Up 30% yoy and over 3% month to month, according to SIA. Just about all semiconductor and equipment companies are offering strong guidance going forward with no indication of weakness anytime soon. Most claiming they see the shortage lasting through 2022 (MRVL the most recent). This shortage combined with the global expansion taking place AND the evolution of the industry's super "cycle" indicates a strong long term outlook for the industry. Who stands to benefit the most? TSM of course. Along with ASML with their monopoly on advanced EUV that's in great demand by anyone wanting to compete in producing advanced semiconductors. AMAT is the most diversified equipment provider. KLAC is the dominant PDC supplier. MRVL for (5G and Data Center) infrastructure. LRCX for memory. ICHR and UCTT are extreme value plays right now as well that benefit from having the companies listed above as customers. GLTA!
  • J
    Jeffrey
    CGTX
    Initiated by Oppenheimer Holdings Outperform » USD 22
    Initiated by B. Riley » Buy » USD 27
  • J
    Janet
    CLS
    Maintains CIBC World Markets Neutral CAD 12.5 » CAD 14.5
    Target Up RBC Capital Sector Perform CAD 12.5 » CAD 14
  • B
    Beverly
    (ARDS) MCap $52 m--2x BIG Phase 3 Drugs NEAR ready =1000%+ Upside
  • J
    Janice
    AYI
    Target Raised by Cowen Outperform USD 184 » USD 223
    Maintains Oppenheimer Holdings Outperform USD 205 » USD 225
    Maintains Credit Suisse Outperform USD 209 » USD 225
    Target Raised by Robert W Baird Outperform » USD 216 » USD 235